ArticleFrontiers in pharmacology2018
3-Bromopyruvate as an Alternative Option for the Treatment of Protothecosis.
Article in Frontiers in pharmacology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed, 19 citations in OpenAlex.
- Epidemiological Characteristics and Antimicrobial Resistance ofInfection and drug resistance · 2026Article
- 3-bromopyruvate induces morphological alteration and may initiate programmed cell death in Cryptococcus neoformans cells.Archives of microbiology · 2024Article
- Successful Treatment of Cutaneous Protothecosis Due toClinical, cosmetic and investigational dermatology · 2024Article
- Drug Susceptibility Profiling ofAntimicrobial agents and chemotherapy · 2023Article
- Integration of transcriptomics, proteomics, and metabolomics data for the detection of the human pathogenicFrontiers in cellular and infection microbiology · 2023Article
- Now for something completely different: Prototheca, pathogenic algae.PLoS pathogens · 2021Review
- Article
- Preliminary Results, Perspectives, and Proposal for a Screening Method ofAntimicrobial agents and chemotherapy · 2020Article
- Review
- In Vitro Activity of 3-Bromopyruvate, an Anticancer Compound, Against Antibiotic-Susceptible and Antibiotic-ResistantCancers · 2019Article
- Genotyping and drug susceptibility profiling of Prototheca sp. strains isolated from cases of protothecosis in dogs.Journal of veterinary internal medicineArticle
- Protothecosis in Dogs: A Narrative Review.Journal of veterinary internal medicineReview
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.